Predictors of Sustained Response to Infliximab in Patients With Crohn's Disease: A Single Cohort Study

被引：0
|
作者：
Duricova, Dana
Malickova, Karin
Bortlik, Martin
Machkova, Nadezda
Komarek, Viktor
Bouzkova, Eva
Lukas, Milan
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S593 / S593
页数：1
相关论文
共 50 条
  • [21] Prediction of Sustained Remission After Discontinuation of Infliximab in Patients With Crohn's Disease
    Papamichail, Konstantinos
    Casteele, Niels Vande
    Hauenstein, Scott
    Princen, Fred
    Singh, Sharat
    Ferrante, Marc
    van Assche, Gert A.
    Rutgeerts, Paul J.
    Gils, Ann
    Vermeire, Severine
    GASTROENTEROLOGY, 2014, 146 (05) : S457 - S457
  • [22] Outcome of continued infliximab therapy in Crohn's disease patients with response but without remission after one year of infliximab - a retrospective cohort study
    Buhl, Sine
    Borghede, Marta Kristina
    Brynskov, Jorn
    Steenholdt, Casper
    Rasmussen, Maria
    Ainsworth, Mark Andrew
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (08) : 930 - 937
  • [23] A Single Biomarker Panel Predicts Response to Infliximab in Patients With Crohn's Disease and Ulcerative Colitis
    Westra, Willem
    Vy Hoang
    Laifenfeld, Daphna
    GASTROENTEROLOGY, 2013, 144 (05) : S192 - S192
  • [24] An open label study of adalimumab in Crohn's disease patients with a loss of response to infliximab
    Anwar, Malik
    O'Sullivan, Maria
    Ryan, Barbara
    Breslin, Niall
    O'Connor, Humphrey
    O'Morain, Colm
    GASTROENTEROLOGY, 2006, 130 (04) : A662 - A662
  • [25] Strictures and response to infliximab in Crohn's disease
    Weinberg, AM
    Rattan, S
    Lewis, JD
    Su, CY
    Katzka, DA
    Deren, J
    Lichtenstein, GR
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S255 - S255
  • [26] Smoking and response to infliximab in Crohn's disease
    Weinberg, AM
    Aberra, FN
    Su, CY
    Rattan, S
    Lichtenstein, GR
    GASTROENTEROLOGY, 2003, 124 (04) : A208 - A209
  • [27] Prediction of response to infliximab in Crohn's disease
    Chaudhary, R
    Ghosh, S
    DIGESTIVE AND LIVER DISEASE, 2005, 37 (08) : 559 - 563
  • [28] Mean Platelet Volume in Crohn's Disease Patients Predicts Sustained Response to a 52-Week Infliximab Therapy: A Pilot Study
    Sobolewska, Aleksandra
    Wlodarczyk, Marcin
    Stec-Michalska, Krystyna
    Fichna, Jakub
    Wisniewska-Jarosinska, Maria
    DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (02) : 542 - 549
  • [29] Mean Platelet Volume in Crohn’s Disease Patients Predicts Sustained Response to a 52-Week Infliximab Therapy: A Pilot Study
    Aleksandra Sobolewska
    Marcin Włodarczyk
    Krystyna Stec-Michalska
    Jakub Fichna
    Maria Wiśniewska-Jarosińska
    Digestive Diseases and Sciences, 2016, 61 : 542 - 549
  • [30] Factors associated with the loss of response to infliximab in patients with Crohn's disease
    Sono, Koji
    Yamada, Akihiro
    Yoshimatsu, Yasushi
    Takada, Nobua
    Suzuki, Yasuo
    CYTOKINE, 2012, 59 (02) : 410 - 416
12345